HOMEPostContact Us
Posted December 03. 2012 2:48PM

U.S. Supreme Court to review lawsuits over flaws in generic drugs

Click headline or here to open angled item
The court agreed to review a bid by Mutual Pharmaceutical Co to overturn a $21 million jury award to Karen Bartlett, a New Hampshire woman who had taken its generic non-steroidal anti-inflammatory drug sulindac for shoulder pain.